Literature DB >> 9093654

Respiratory symptoms and lung function abnormalities among machine operators in automobile production.

N L Sprince1, P S Thorne, W Popendorf, C Zwerling, E R Miller, J A DeKoster.   

Abstract

This cross-sectional study was designed to assess differences in prevalence of respiratory symptoms and lung function between machine operators exposed to semisynthetic or soluble metal-working fluids (MWFs) and unexposed assemblers and to assess exposure-response relationships with MWF type, total aerosol, endotoxin, culturable bacteria and fungi. We evaluated 183 machine operators and 66 assemblers from one large automobile transmission plant using questionnaires, spirometry data, and cross-shift assessment of both lung function and respiratory symptoms. We found that airborne exposures to total aerosol, endotoxin, culturable bacteria and fungi were higher in machine operations than in the assembly area. There was a correlation between bulk and airborne culturable bacteria, but not between bulk and airborne culturable fungi. Machine operators had significantly more usual cough, usual phlegm, work-related chest tightness and post-shift symptoms of chest tightness, throat irritation, and cough compared with assemblers. We found exposure-response relationships between respiratory symptoms and total aerosol, as well as culturable fungi and bacteria. Associations with endotoxin were not strong or consistent, possibly because airborne levels were generally low. Cross-shift lung function decrements did not differ between machine operators and assemblers and there were no associations with MWF or specific exposures. The finding of respiratory symptoms at low levels of exposure in this study suggests the need to re-assess total aerosol thresholds. Associations between airborne fungal exposures and respiratory symptoms need further study to characterize sources of exposure other than MWF in machining operations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093654     DOI: 10.1002/(sici)1097-0274(199704)31:4<403::aid-ajim5>3.0.co;2-w

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  7 in total

1.  Clinical investigation of an outbreak of alveolitis and asthma in a car engine manufacturing plant.

Authors:  W Robertson; A S Robertson; C B S G Burge; V C Moore; M S Jaakkola; P A Dawkins; M Burd; R Rawbone; I Gardner; M Kinoulty; B Crook; G S Evans; J Harris-Roberts; S Rice; P S Burge
Journal:  Thorax       Date:  2007-05-15       Impact factor: 9.139

2.  Lung function in asphalt pavers: a longitudinal study.

Authors:  Bente Ulvestad; Britt Grethe Randem; Øivind Skare; Trond Mogens Aaløkken; Georg Karl Myranek; Karine Elihn; May Brit Lund
Journal:  Int Arch Occup Environ Health       Date:  2016-10-08       Impact factor: 3.015

3.  Occupational respiratory and skin diseases among Finnish machinists: findings of a large clinical study.

Authors:  Timo Hannu; Katri Suuronen; Kristiina Aalto-Korte; Kristiina Alanko; Ritva Luukkonen; Merja Järvelä; Riitta Jolanki; Maritta S Jaakkola
Journal:  Int Arch Occup Environ Health       Date:  2012-03-16       Impact factor: 3.015

4.  Historical cohort study of a New Zealand foundry and heavy engineering plant.

Authors:  H M Firth; J M Elwood; B Cox; G P Herbison
Journal:  Occup Environ Med       Date:  1999-02       Impact factor: 4.402

5.  Metalworking fluid with mycobacteria and endotoxin induces hypersensitivity pneumonitis in mice.

Authors:  Peter S Thorne; Andrea Adamcakova-Dodd; Kevin M Kelly; Marsha E O'neill; Caroline Duchaine
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

6.  Respiratory health effects of exposure to low levels of airborne endotoxin - a systematic review.

Authors:  Azadèh Farokhi; Dick Heederik; Lidwien A M Smit
Journal:  Environ Health       Date:  2018-02-08       Impact factor: 5.984

7.  Risk Assessment for Metalworking Fluids and Respiratory Outcomes.

Authors:  Robert M Park
Journal:  Saf Health Work       Date:  2019-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.